Biotechnology Today
more-
Delayed TIL 2024: FDA resource constraints push back decision on Iovance cell therapy
The FDA has provided yet another twist in the Iovance Biotherapeutics saga. After years of…
As White House mulls microbe research, microbiologists chime in with calls for standardized practices
BMS trims anti-TIGIT pipeline and a handful of other early- to midstage meds
Mammogram AI shows more promise, performing as well as radiologists in breast cancer screening study
Sanofi slings long-dormant Alzheimer’s asset to First Wave for repurposing, secures buy back rights
Markets
more-
Weekly Market Review – November 25, 2023
Stock Markets The past week was a holiday-shortened trading week as the Thanksgiving celebration closed…
Bio Space
more
Rise and shine: AWAK Technologies takes in $20M for portable dialysis system
A new day has dawned for AWAK Technologies, the maker…
Carl June, Vertex execs and Parkinson’s scientists win Breakthrough prizes
CAR-T cell therapy pioneer Carl June, M.D., and scientists from…
Akili cuts workforce another 40%, pivots to selling digital therapeutics over the counter
It’s been a tough year for makers of prescription digital…
Global News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Delayed TIL 2024: FDA resource constraints push back decision on Iovance cell therapy
As White House mulls microbe research, microbiologists chime in with calls for standardized practices
BMS trims anti-TIGIT pipeline and a handful of other early- to midstage meds
Mammogram AI shows more promise, performing as well as radiologists in breast cancer screening study
Rise and shine: AWAK Technologies takes in $20M for portable dialysis system
Carl June, Vertex execs and Parkinson’s scientists win Breakthrough prizes
Akili cuts workforce another 40%, pivots to selling digital therapeutics over the counter
AbbVie cuts ties to Harpoon’s BCMA trispecific, puncturing dream of $200M payday
Sanofi slings long-dormant Alzheimer’s asset to First Wave for repurposing, secures buy back rights
NeurAxis neuromod therapy improves symptoms for teens with painful GI disorders: study